Wyden Probes Formula Maker's Stock Buybacks Amid Shortage

By Joshua Rosenberg · May 18, 2022, 5:28 PM EDT

Abbott Laboratories helped trigger a baby formula shortage by apparently neglecting the state of its manufacturing infrastructure as it spent billions on stock buybacks, Senate Finance Committee Chair Ron Wyden said...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login